Journal: EMBO Molecular Medicine
Article Title: CDK12/CDK13 inhibition disrupts transcriptional elongation and replication fork progression in glioblastoma
doi: 10.1038/s44321-026-00393-w
Figure Lengend Snippet: ( A ) Dose-response curves from MTT assays for eleven high-grade glioblastoma and seven non-glioblastoma cell lines treated with THZ531. Data represent mean ± SD of three replicates. ( B ) Bar graph showing IC50 values from the MTT assays in ( A ). Statistical analyses confirm that the IC50 values for GSCs are significantly different from those of non-GSC cells. Data were analyzed by the Mann–Whitney t -test. ( C ) In vitro cell proliferation assay of the GSCs G7 and G144, and HeLa cells treated as indicated. Data represent mean ± SD of three replicates. Data were analyzed by two-way ANOVA followed by Tukey’s multiple comparisons test. Exact p values are provided in Appendix Table . ( D ) Clonogenic survival assay of G7, G144, and HeLa cells treated as indicated. ( E ) Immuno-blot analyses from G7, G144, and HeLa cells that were treated with DMSO, 500 nM THZ531 for 6, 24, and 48 h to assess total and cleaved PARP as a marker of apoptosis, with Vinculin used as a loading control. ( F ) Flow cytometry quantification of the TUNEL assay showing the percentage of apoptotic G7 cells treated with 500 nM THZ531 for 6 and 24 h. ( G ) Competition assays of sgRNAs targeting CDK9, CDK12 and CDK13, as well as positive controls (essential genes, MCM2 and RPS19). Non-targeting sgRNA (NC) was used as a negative control. Data were analyzed by two-way ANOVA followed by Tukey’s multiple comparisons test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, significant differences as compared to the day 0. Exact p values are provided in Appendix Table . .
Article Snippet: Click-iT Plus EdU Alexa Fluor 594 Flow Cytometry Assay Kit , Fisher Scientific , C10646.
Techniques: MANN-WHITNEY, In Vitro, Proliferation Assay, Clonogenic Cell Survival Assay, Marker, Control, Flow Cytometry, TUNEL Assay, Negative Control